<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-20877" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Ecthyma Gangrenosum</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Shah</surname>
            <given-names>Muneeb</given-names>
          </name>
          <aff>Penn State Health</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Crane</surname>
            <given-names>Jonathan S.</given-names>
          </name>
          <aff>Sampson Regional Med Ctr / Campbell Univ</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Muneeb Shah declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Jonathan Crane declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>28</day>
          <month>6</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-20877.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Ecthyma gangrenosum (EG) is a cutaneous infection that most commonly occurs in immunocompromised individuals with fulminant bacteremia. EG was first described in 1897 by Canadian pathologist Dr. Lewellys Barker as a manifestation of Pseudomonas aeruginosa. Although P. aeruginosa remains the most frequent organism identified in EG, other causative pathogens have since been described. This activity reviews the cause and presentation of ecthyma gangrenosum and highlights the interprofessional team's role in its management.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Review the causes of ecthyma gangrenosum.</p></list-item><list-item><p>Describe the presentation of ecthyma gangrenosum.</p></list-item><list-item><p>Summarize the treatment options for ecthyma gangrenosum.</p></list-item><list-item><p>Explain the importance of improving care coordination among interprofessional team members to improve outcomes for patients affected by ecthyma gangrenosum.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=20877&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=20877">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-20877.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Ecthyma gangrenosum (EG) is a cutaneous infection that most commonly occurs in immunocompromised individuals with fulminant bacteremia. EG was first described in 1897 by Canadian pathologist Dr. Lewellys&#x000a0;Barker as a manifestation of <italic toggle="yes">Pseudomonas </italic><italic toggle="yes">aeruginosa.</italic><xref ref-type="bibr" rid="article-20877.r1">[1]</xref>&#x000a0;Although&#x000a0;<italic toggle="yes">P.&#x000a0;aeruginosa </italic>remains the most frequent organism identified&#x000a0;in EG, other causative pathogens have since&#x000a0;been described. Lesions appear as gangrenous ulcers with erythematous borders. EG&#x000a0;predominantly affects the axillary and anogenital areas, but the arms, legs, trunk, and face are also sometimes involved. Perivascular invasion and resultant ischemic necrosis of the associated skin result in the classic macroscopic appearance. Prompt recognition and empiric therapy with broad-spectrum antipseudomonal agents are of critical importance. Once microbiology results identify the causative pathogen and sensitivities are available, antimicrobial coverage should be narrowed.<xref ref-type="bibr" rid="article-20877.r2">[2]</xref>&#x000a0;EG denotes a poor prognosis, particularly in immunocompromised individuals with neutropenia.</p>
      </sec>
      <sec id="article-20877.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p><italic toggle="yes">P.&#x000a0;aeruginosa&#x000a0;</italic>is the most frequent organism identified in ecthyma gangrenosum, with one study identifying&#x000a0;<italic toggle="yes">P.&#x000a0;aeruginosa&#x000a0;</italic>in 74% of cases.<xref ref-type="bibr" rid="article-20877.r1">[1]</xref>&#x000a0;<italic toggle="yes">P. aeruginosa</italic> is a non-lactose fermenting gram-negative aerobic, rod-shaped bacteria. The organism is found in moist environments,&#x000a0;is often identified in tap water samples, and can contaminate&#x000a0;hospital equipment leading to nosocomial infections.<xref ref-type="bibr" rid="article-20877.r3">[3]</xref><xref ref-type="bibr" rid="article-20877.r4">[4]</xref>&#x000a0;Other causes of EG include methicillin-resistant <italic toggle="yes">Staphylococcus aureus</italic> (MRSA), <italic toggle="yes">Streptococcus pyogenes</italic>,&#x000a0;<italic toggle="yes">Citrobacter&#x000a0;freundii</italic>,&#x000a0;E<italic toggle="yes">scherichia coli</italic>,&#x000a0;<italic toggle="yes">Aeromonas hydrophila</italic>, <italic toggle="yes">Klebsiella pneumoniae</italic>, <italic toggle="yes">Serratia marcescens</italic>, <italic toggle="yes">Xanthomonas maltophilia</italic>, <italic toggle="yes">Morganella morganii</italic>, <italic toggle="yes">Corynebacterium diphtheriae</italic>, <italic toggle="yes">Neisseria gonorrhea</italic>, <italic toggle="yes">Yersinia pestis</italic>, fungi like the&#x000a0;<italic toggle="yes">Candida</italic>&#x000a0;species), and viruses like herpes simplex virus.<xref ref-type="bibr" rid="article-20877.r1">[1]</xref><xref ref-type="bibr" rid="article-20877.r5">[5]</xref><xref ref-type="bibr" rid="article-20877.r6">[6]</xref><xref ref-type="bibr" rid="article-20877.r7">[7]</xref></p>
      </sec>
      <sec id="article-20877.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Ecthyma gangrenosum affects all age groups and genders. Immunocompromised individuals are&#x000a0;particularly&#x000a0;susceptible&#x000a0;to developing this condition, with up to 62% to 75% of affected individuals having an underlying immunodeficiency.<xref ref-type="bibr" rid="article-20877.r1">[1]</xref><xref ref-type="bibr" rid="article-20877.r8">[8]</xref>&#x000a0;EG&#x000a0;is also known to occur in otherwise healthy immunocompetent individuals.<xref ref-type="bibr" rid="article-20877.r9">[9]</xref>&#x000a0;Common predisposing conditions include neutropenia, leukemia, multiple myeloma, diabetes mellitus, malnutrition, and extensive burn wounds.<xref ref-type="bibr" rid="article-20877.r1">[1]</xref><xref ref-type="bibr" rid="article-20877.r5">[5]</xref><xref ref-type="bibr" rid="article-20877.r7">[7]</xref><xref ref-type="bibr" rid="article-20877.r10">[10]</xref><xref ref-type="bibr" rid="article-20877.r11">[11]</xref></p>
      </sec>
      <sec id="article-20877.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Ecthyma&#x000a0;gangrenosum&#x000a0;is separated into bacteremic and non-bacteremic forms.<xref ref-type="bibr" rid="article-20877.r7">[7]</xref>&#x000a0;The bacteremic form of EG is more common than the non-bacteremic form.<xref ref-type="bibr" rid="article-20877.r1">[1]</xref>&#x000a0;With bacteremia, the causative organism is spread hematogenously to the capillaries and invades the media and adventitia of arteries and veins. Perivascular invasion ultimately leads to ischemic necrosis of the surrounding skin.<xref ref-type="bibr" rid="article-20877.r12">[12]</xref>&#x000a0;In the non-bacteremic form, the lesions develop at the location of direct inoculation into the epidermis. Virulence toxins and enzymes produced by <italic toggle="yes">P. aeruginosa</italic>, such as exotoxin A, elastase, and phospholipase C,<italic toggle="yes">&#x000a0;</italic>cause skin and vascular destruction.<xref ref-type="bibr" rid="article-20877.r8">[8]</xref>&#x000a0;Multi-drug resistance of<italic toggle="yes">&#x000a0;P. aeruginosa</italic>&#x000a0;has increased substantially&#x000a0;in recent years, making treatment more challenging. Resistance mechanisms include decreased permeability (biofilm formation), antibiotic efflux pumps, antibiotic inactivating mechanisms, and antibiotic target site mutations.<xref ref-type="bibr" rid="article-20877.r12">[12]</xref><xref ref-type="bibr" rid="article-20877.r13">[13]</xref></p>
      </sec>
      <sec id="article-20877.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Excisional biopsy or punch biopsy&#x000a0;with Gram stain, culture, and histopathologic examination can&#x000a0;be performed in equivocal cases. In cases of pseudomonal&#x000a0;EG, Gram stain shows&#x000a0;many gram-negative, rod-shaped bacteria.<xref ref-type="bibr" rid="article-20877.r14">[14]</xref>&#x000a0;Wound cultures are frequently positive for <italic toggle="yes">P. aeruginosa</italic> but may reveal a different causative organism<italic toggle="yes">.</italic> Microscopic examination reveals an ulcerated zone of necrotic epidermis and dermis with neutrophilic predominance.<xref ref-type="bibr" rid="article-20877.r14">[14]</xref><xref ref-type="bibr" rid="article-20877.r15">[15]</xref>&#x000a0;The epidermis adjacent to the necrotic region reveals reactive hyperkeratosis. The underlying subcutaneous tissue may also be involved.<xref ref-type="bibr" rid="article-20877.r8">[8]</xref></p>
      </sec>
      <sec id="article-20877.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>When acquiring a history on presentation, it is important to note the temporal evolution of the lesions, the location of the lesions, any underlying immunosuppressive condition, and other associated symptoms such as&#x000a0;cough, fever, or dysuria. In individuals with the bacteremic form of EG,&#x000a0;the source of infection is important to ascertain. For example, productive cough or dysuria may reveal a respiratory or urinary source, respectively. In the non-bacteremic form, it is important to note any trauma that may have introduced the infection via direct inoculation.</p>
        <p>The lesions of ecthyma gangrenosum begin as painless, round erythematous macules and patches that develop into central pustules with surrounding erythema. A hemorrhagic vesicle appears at the center of the lesion and evolves into a gangrenous ulcer with a black eschar.<xref ref-type="bibr" rid="article-20877.r1">[1]</xref><xref ref-type="bibr" rid="article-20877.r8">[8]</xref>&#x000a0;Early lesions may progress to necrotic ulcers in as little as 12 hours.<xref ref-type="bibr" rid="article-20877.r8">[8]</xref>&#x000a0;The&#x000a0;lesions can&#x000a0;be localized&#x000a0;and solitary, or widespread.<xref ref-type="bibr" rid="article-20877.r1">[1]</xref>&#x000a0;</p>
        <p>EG can appear anywhere in the body but most commonly affects the anogenital and axillary areas. The gluteal/perineal area is most common (57%), followed by the extremities (30%), the trunk (6%), and the face (6%).<xref ref-type="bibr" rid="article-20877.r8">[8]</xref>&#x000a0;Rare cases of periorbital involvement have also been reported.<xref ref-type="bibr" rid="article-20877.r8">[8]</xref>&#x000a0;The entire body should be examined for lesions, and any fluctuance or large areas of necrosis should be noted.</p>
      </sec>
      <sec id="article-20877.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Initial evaluation includes blood cultures, wound cultures, urinalysis, chest radiograph, complete blood count, comprehensive metabolic panel, C-reactive protein, and HIV testing. Procalcitonin and lactate levels are important in those with&#x000a0;EG in the setting of sepsis. Evaluation of the lesions with a Wood's lamp may expedite the diagnosis, as&#x000a0;<italic toggle="yes">P. aeruginosa </italic>will appear with green fluorescence.<xref ref-type="bibr" rid="article-20877.r8">[8]</xref><xref ref-type="bibr" rid="article-20877.r16">[16]</xref>&#x000a0;Excisional&#x000a0;or&#x000a0;punch biopsy can&#x000a0;be performed in equivocal cases.</p>
      </sec>
      <sec id="article-20877.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>In individuals with suspected ecthyma gangrenosum,&#x000a0;prompt treatment&#x000a0;with broad-spectrum antibiotics should&#x000a0;be&#x000a0;initiated after obtaining blood and wound cultures.&#x000a0;</p>
        <p>Initial empiric therapy includes antipseudomonal&#x000a0;beta-lactams (piperacillin/tazobactam), cephalosporins (cefepime), fluoroquinolones (levofloxacin), and&#x000a0;carbapenems (imipenem). Combination therapy&#x000a0;is recommended&#x000a0;in high-risk individuals, such as those with neutropenia and septic shock.<xref ref-type="bibr" rid="article-20877.r12">[12]</xref>&#x000a0;Once the&#x000a0;causative organism and antimicrobial susceptibilities&#x000a0;are identified, antimicrobial coverage should be narrowed.<xref ref-type="bibr" rid="article-20877.r2">[2]</xref>&#x000a0;In rare cases&#x000a0;with a fungal or viral&#x000a0;etiology,&#x000a0;anti-fungal and anti-viral agents should be started.</p>
        <p>Surgical excision of necrotic lesions or abscesses is often necessary. Incision and drainage of abscesses are important for source control of the infection. For necrotic skin lesions, aggressive debridement and grafting may be necessary for lesions larger than 10 cm.<xref ref-type="bibr" rid="article-20877.r8">[8]</xref></p>
        <p>Treatment in the hospital intensive care setting is appropriate for&#x000a0;patients with sepsis or neutropenia due to the high case fatality rate. For those with non-bacteremic EG, treatment in the outpatient setting may be appropriate. In this setting, oral antipseudomonal agents, such as ciprofloxacin, can be considered.</p>
      </sec>
      <sec id="article-20877.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>A thorough history, physical, and basic laboratory studies help differentiate between EG and other causes of skin necrosis. Neutropenia and malignancy in a patient with typical skin lesions should raise suspicion for EG.&#x000a0;Other conditions with similar macroscopic features include autoimmune vasculitides, vasopressor-induced necrosis, calciphylaxis, warfarin-induced necrosis, and disseminated intravascular coagulation (DIC), pyoderma gangrenosum,&#x000a0;necrolytic migratory erythema, and&#x000a0;livedoid vasculopathy.<xref ref-type="bibr" rid="article-20877.r1">[1]</xref><xref ref-type="bibr" rid="article-20877.r17">[17]</xref><xref ref-type="bibr" rid="article-20877.r18">[18]</xref></p>
        <p>In individuals with underlying malignancy and pancytopenia,&#x000a0;fibrinogen levels and fibrin split products (d-dimer) can help differentiate DIC from EG. In individuals in the intensive care unit on vasopressors, the distribution of lesions can help differentiate between vasopressor-induced necrosis and EG.&#x000a0;Vasopressor-induced necrosis affects the distal extremities, while EG affects the anogenital and axillary areas.<xref ref-type="bibr" rid="article-20877.r19">[19]</xref>&#x000a0;Tissue samples&#x000a0;are critical when the diagnosis is not clear based on less invasive methods.<xref ref-type="bibr" rid="article-20877.r20">[20]</xref></p>
      </sec>
      <sec id="article-20877.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The development of&#x000a0;EG&#x000a0;lesions in individuals with sepsis&#x000a0;is associated with a poor prognosis and is fatal in 20% to 77% of patients.<xref ref-type="bibr" rid="article-20877.r15">[15]</xref><xref ref-type="bibr" rid="article-20877.r21">[21]</xref>&#x000a0;In individuals with non-bacteremic EG, the mortality rate is significantly lower at 8%.<xref ref-type="bibr" rid="article-20877.r15">[15]</xref>&#x000a0;The underlying&#x000a0;immunosuppressive state (e.g., malignancy, renal failure, or other) is often the main determinant of clinical outcome.<xref ref-type="bibr" rid="article-20877.r22">[22]</xref>&#x000a0;The presence of neutropenia at the time of diagnosis is the most important prognostic factor of mortality.<xref ref-type="bibr" rid="article-20877.r21">[21]</xref></p>
      </sec>
      <sec id="article-20877.s12" sec-type="Complications">
        <title>Complications</title>
        <p>EG&#x000a0;is a life-threatening infection often&#x000a0;complicated by septic shock. Prompt clinician recognition and appropriate antimicrobial therapy&#x000a0;are necessary to achieve optimal outcomes.</p>
      </sec>
      <sec id="article-20877.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients need to understand that if they are immunocompromised, that underlying condition requires optimal management. These patients are typically managed in the hospital setting.</p>
      </sec>
      <sec id="article-20877.s14" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <list list-type="bullet">
          <list-item>
            <p><italic toggle="yes">P. aeruginosa&#x000a0;</italic>is the most common causative organism of ecthyma gangrenosum.</p>
          </list-item>
          <list-item>
            <p>Lesions appear as gangrenous ulcers with erythematous borders located predominantly in the axillary and anogenital areas.</p>
          </list-item>
          <list-item>
            <p>Nearly all individuals with typical skin lesions are immunocompromised, with malignancy being the most common underlying disease state.</p>
          </list-item>
          <list-item>
            <p>Neutropenia at the time of diagnosis is the most important prognostic factor.</p>
          </list-item>
          <list-item>
            <p>Prompt treatment with intravenous&#x000a0;antipseudomonal agents&#x000a0;is indicated.</p>
          </list-item>
          <list-item>
            <p>Incision and drainage may be performed for abscesses.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-20877.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Management of ecthyma gangrenosum requires an interprofessional team approach, including providers from infectious disease, surgery, dermatology, hematology, and critical care.&#x000a0;The providers involved in treatment&#x000a0;depend on the overall clinical picture and whether they are being treated in the intensive care unit.</p>
        <p>A dermatologist can help in the initial diagnostic workup to determine the cause (Wood's lamp evaluation, punch biopsy) and extent of the lesions.&#x000a0;Infectious&#x000a0;disease specialists&#x000a0;are helpful to determine the selection and&#x000a0;length of antibiotic therapy.&#x000a0;Surgeons&#x000a0;may be needed&#x000a0;for incision and drainage of multiple abscesses, surgical debridement of necrotic lesions, or grafting of large-area defects.&#x000a0;In patients with neutropenia,&#x000a0;granulocyte colony-stimulating factor (G-CSF) may be given&#x000a0;at the discretion of a hematologist.</p>
        <p>For individuals with fulminant sepsis, management in the critical care setting by an intensivist&#x000a0;is&#x000a0;appropriate&#x000a0;due to the high fatality rate of bacteremic&#x000a0;EG.&#x000a0;Individuals with sepsis are extremely&#x000a0;tenuous, and careful monitoring from the nursing staff with frequent vital sign measurements is critical and reporting to the team untoward changes. Prompt administration of effective antimicrobial therapy&#x000a0;is&#x000a0;known&#x000a0;to improve survival in sepsis.<xref ref-type="bibr" rid="article-20877.r23">[23]</xref>&#x000a0;[Level&#x000a0;1] Ideally, an infectious disease specialist pharmacist should assist with antibiotic selection and assist the team with dose management. In addition to helping to target the causative organism. Early&#x000a0;goal-directed therapy focusing on blood pressure and oxygen saturation&#x000a0;has also&#x000a0;been shown to improve outcomes and reduce mortality in sepsis.<xref ref-type="bibr" rid="article-20877.r24">[24]</xref>&#x000a0;[Level 1]</p>
      </sec>
      <sec id="article-20877.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=20877&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=20877">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/infectious-disease/ecthyma-gangrenosum/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=20877">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/20877/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=20877">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-20877.s17">
        <title>References</title>
        <ref id="article-20877.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vaiman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lazarovitch</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Heller</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Lotan</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Ecthyma gangrenosum and ecthyma-like lesions: review article.</article-title>
            <source>Eur J Clin Microbiol Infect Dis</source>
            <year>2015</year>
            <month>Apr</month>
            <volume>34</volume>
            <issue>4</issue>
            <fpage>633</fpage>
            <page-range>633-9</page-range>
            <pub-id pub-id-type="pmid">25407372</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20877.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Leekha</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Terrell</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Edson</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>General principles of antimicrobial therapy.</article-title>
            <source>Mayo Clin Proc</source>
            <year>2011</year>
            <month>Feb</month>
            <volume>86</volume>
            <issue>2</issue>
            <fpage>156</fpage>
            <page-range>156-67</page-range>
            <pub-id pub-id-type="pmid">21282489</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20877.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mulcahy</surname>
                <given-names>LR</given-names>
              </name>
              <name>
                <surname>Isabella</surname>
                <given-names>VM</given-names>
              </name>
              <name>
                <surname>Lewis</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Pseudomonas aeruginosa biofilms in disease.</article-title>
            <source>Microb Ecol</source>
            <year>2014</year>
            <month>Jul</month>
            <volume>68</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-12</page-range>
            <pub-id pub-id-type="pmid">24096885</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20877.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Georgieva</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Dimitrova</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Study of the Microbiological Quality of Bulgarian Bottled Water in Terms of Its Contamination with Pseudomonas Aeruginosa.</article-title>
            <source>Cent Eur J Public Health</source>
            <year>2016</year>
            <month>Dec</month>
            <volume>24</volume>
            <issue>4</issue>
            <fpage>326</fpage>
            <page-range>326-330</page-range>
            <pub-id pub-id-type="pmid">28095290</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20877.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hawkley</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Pollard</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Ferraro</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Ecthyma gangrenosum caused by <italic>Citrobacter freundii</italic>.</article-title>
            <source>BMJ Case Rep</source>
            <year>2017</year>
            <month>Jul</month>
            <day>27</day>
            <volume>2017</volume>
            <pub-id pub-id-type="pmid">28751433</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20877.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>R G</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Muralidhar</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Non-pseudomonal ecthyma gangrenosum caused by methicillin-resistant S<italic>taphylococcus aureus</italic> (MRSA) in a chronic alcoholic patient.</article-title>
            <source>BMJ Case Rep</source>
            <year>2017</year>
            <month>Aug</month>
            <day>03</day>
            <volume>2017</volume>
            <pub-id pub-id-type="pmid">28775089</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20877.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reich</surname>
                <given-names>HL</given-names>
              </name>
              <name>
                <surname>Williams Fadeyi</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Naik</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Honig</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Yan</surname>
                <given-names>AC</given-names>
              </name>
            </person-group>
            <article-title>Nonpseudomonal ecthyma gangrenosum.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2004</year>
            <month>May</month>
            <volume>50</volume>
            <issue>5 Suppl</issue>
            <fpage>S114</fpage>
            <page-range>S114-7</page-range>
            <pub-id pub-id-type="pmid">15097944</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20877.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vaiman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lasarovitch</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Heller</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Lotan</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Ecthyma gangrenosum versus ecthyma-like lesions: should we separate these conditions?</article-title>
            <source>Acta Dermatovenerol Alp Pannonica Adriat</source>
            <year>2015</year>
            <volume>24</volume>
            <issue>4</issue>
            <fpage>69</fpage>
            <page-range>69-72</page-range>
            <pub-id pub-id-type="pmid">26697730</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20877.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Biscaye</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Demonchy</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Afanetti</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dupont</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Haas</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Tran</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Ecthyma gangrenosum, a skin manifestation of Pseudomonas aeruginosa sepsis in a previously healthy child: A case report.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>96</volume>
            <issue>2</issue>
            <fpage>e5507</fpage>
            <pub-id pub-id-type="pmid">28079790</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20877.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Korte</surname>
                <given-names>AKM</given-names>
              </name>
              <name>
                <surname>Vos</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Ecthyma Gangrenosum.</article-title>
            <source>N Engl J Med</source>
            <year>2017</year>
            <month>Dec</month>
            <day>07</day>
            <volume>377</volume>
            <issue>23</issue>
            <fpage>e32</fpage>
            <pub-id pub-id-type="pmid">29211664</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20877.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bettens</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Delaere</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Glupczynski</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Schoevaerdts</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Swine</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Ecthyma gangrenosum in a non-neutropaenic, elderly patient: case report and review of the literature.</article-title>
            <source>Acta Clin Belg</source>
            <year>2008</year>
            <season>Nov-Dec</season>
            <volume>63</volume>
            <issue>6</issue>
            <fpage>394</fpage>
            <page-range>394-7</page-range>
            <pub-id pub-id-type="pmid">19170356</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20877.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bassetti</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vena</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Croxatto</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Righi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Guery</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>How to manage <italic>Pseudomonas aeruginosa</italic> infections.</article-title>
            <source>Drugs Context</source>
            <year>2018</year>
            <volume>7</volume>
            <fpage>212527</fpage>
            <pub-id pub-id-type="pmid">29872449</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20877.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Yoon</surname>
                <given-names>SS</given-names>
              </name>
            </person-group>
            <article-title><italic>Pseudomonas aeruginosa</italic> Biofilm, a Programmed Bacterial Life for Fitness.</article-title>
            <source>J Microbiol Biotechnol</source>
            <year>2017</year>
            <month>Jun</month>
            <day>28</day>
            <volume>27</volume>
            <issue>6</issue>
            <fpage>1053</fpage>
            <page-range>1053-1064</page-range>
            <pub-id pub-id-type="pmid">28301918</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20877.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Frey</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Latkowski</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Louie</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Chiu</surname>
                <given-names>ES</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and management of ecthyma gangrenosum in chronic renal failure patient.</article-title>
            <source>Arch Plast Surg</source>
            <year>2014</year>
            <month>May</month>
            <volume>41</volume>
            <issue>3</issue>
            <fpage>299</fpage>
            <page-range>299-301</page-range>
            <pub-id pub-id-type="pmid">24883286</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20877.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sarkar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Patra</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Mondal</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Ecthyma gangrenosum in the periorbital region in a previously healthy immunocompetent woman without bacteremia.</article-title>
            <source>Indian Dermatol Online J</source>
            <year>2016</year>
            <season>Jan-Feb</season>
            <volume>7</volume>
            <issue>1</issue>
            <fpage>36</fpage>
            <page-range>36-9</page-range>
            <pub-id pub-id-type="pmid">26955586</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20877.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ponka</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Baddar</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Wood lamp examination.</article-title>
            <source>Can Fam Physician</source>
            <year>2012</year>
            <month>Sep</month>
            <volume>58</volume>
            <issue>9</issue>
            <fpage>976</fpage>
            <pub-id pub-id-type="pmid">22972730</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20877.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ozel Coskun</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Karaman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gorkem</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Bu&#x0011f;day</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Poyrazo&#x0011f;lu</surname>
                <given-names>OK</given-names>
              </name>
              <name>
                <surname>Senel</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Terlipressin-induced ischemic skin necrosis: a rare association.</article-title>
            <source>Am J Case Rep</source>
            <year>2014</year>
            <month>Oct</month>
            <day>31</day>
            <volume>15</volume>
            <fpage>476</fpage>
            <page-range>476-9</page-range>
            <pub-id pub-id-type="pmid">25360696</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20877.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hafner</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Calciphylaxis and Martorell Hypertensive Ischemic Leg Ulcer: Same Pattern - One Pathophysiology.</article-title>
            <source>Dermatology</source>
            <year>2016</year>
            <volume>232</volume>
            <issue>5</issue>
            <fpage>523</fpage>
            <page-range>523-533</page-range>
            <pub-id pub-id-type="pmid">27622522</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20877.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Daroca-P&#x000e9;rez</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Carrascosa</surname>
                <given-names>MF</given-names>
              </name>
            </person-group>
            <article-title>Digital necrosis: a potential risk of high-dose norepinephrine.</article-title>
            <source>Ther Adv Drug Saf</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>8</volume>
            <issue>8</issue>
            <fpage>259</fpage>
            <page-range>259-261</page-range>
            <pub-id pub-id-type="pmid">28781738</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20877.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fernandes</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Baldaia</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gon&#x000e7;alves</surname>
                <given-names>AR</given-names>
              </name>
            </person-group>
            <article-title>Genital Ischemia in a Patient Under Terlipressin Therapy.</article-title>
            <source>GE Port J Gastroenterol</source>
            <year>2016</year>
            <season>Jul-Aug</season>
            <volume>23</volume>
            <issue>4</issue>
            <fpage>224</fpage>
            <page-range>224-225</page-range>
            <pub-id pub-id-type="pmid">28868464</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20877.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mart&#x000ed;nez-Longoria</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Rosales-Solis</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Ocampo-Garza</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Guerrero-Gonz&#x000e1;lez</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Ocampo-Candiani</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Ecthyma gangrenosum: a report of eight cases.</article-title>
            <source>An Bras Dermatol</source>
            <year>2017</year>
            <season>Sep-Oct</season>
            <volume>92</volume>
            <issue>5</issue>
            <fpage>698</fpage>
            <page-range>698-700</page-range>
            <pub-id pub-id-type="pmid">29166510</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20877.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grisaru-Soen</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lerner-Geva</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Keller</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Berger</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Passwell</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Barzilai</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Pseudomonas aeruginosa bacteremia in children: analysis of trends in prevalence, antibiotic resistance and prognostic factors.</article-title>
            <source>Pediatr Infect Dis J</source>
            <year>2000</year>
            <month>Oct</month>
            <volume>19</volume>
            <issue>10</issue>
            <fpage>959</fpage>
            <page-range>959-63</page-range>
            <pub-id pub-id-type="pmid">11055596</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20877.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kumar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Roberts</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Wood</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Light</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Parrillo</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Suppes</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Feinstein</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Zanotti</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Taiberg</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Gurka</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cheang</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock.</article-title>
            <source>Crit Care Med</source>
            <year>2006</year>
            <month>Jun</month>
            <volume>34</volume>
            <issue>6</issue>
            <fpage>1589</fpage>
            <page-range>1589-96</page-range>
            <pub-id pub-id-type="pmid">16625125</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20877.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rivers</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Havstad</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ressler</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Muzzin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Knoblich</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Peterson</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Tomlanovich</surname>
                <given-names>M</given-names>
              </name>
              <collab>Early Goal-Directed Therapy Collaborative Group</collab>
            </person-group>
            <article-title>Early goal-directed therapy in the treatment of severe sepsis and septic shock.</article-title>
            <source>N Engl J Med</source>
            <year>2001</year>
            <month>Nov</month>
            <day>08</day>
            <volume>345</volume>
            <issue>19</issue>
            <fpage>1368</fpage>
            <page-range>1368-77</page-range>
            <pub-id pub-id-type="pmid">11794169</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
